10 Feb Chardan
Chardan is a global investment bank focused on companies with the potential to generate exceptional investment returns by creating real value for society. Chardan is known for high alpha generation, due to Chardan’s market impact and its history of being early to identify and communicate the fundamentals surrounding disruptive companies and their technologies. Chardan is a leader in helping genetic medicines and cell therapy companies achieve their capital markets goals. Chardan has been instrumental in company formation and private company capital raises through IPO, public market transactions and M&A, raising nearly $6 Billion for healthcare companies since 2015. Chardan covers more than 35 cell therapy and genetic medicines companies via our equity research department. Additionally, we host six conferences focused on supporting growth and investment in the space.
